From the magazine LSR 4/2019 | S. 270-273 The following page is 270

Medicines and Medical Devices in the EU Single Market – Dreams and Reality

First AIJA Healthcare Seminar Held in Zurich from 27–29 June 2019

I. Introduction

From 27 to 29 June 2019, 50 participants from 18 countries attended the first AIJA Healthcare Seminar on “Medicines and medical devices in the EU Single Market – dreams and reality” in Zurich.1 The seminar was organized by members of the Association Internationale des Jeunes Avocats (“AIJA”), who had formed a Healthcare Special Interest Group with the goal of being instituted as new Commission of AIJA in the near future.

The topics discussed included parallel trade, the new Clinical Trials Regulation (“CTR”)2, the impact of the new medical devices regulations (“MDRs”)3 on study agreements and distribution contracts, challenges for the healthcare industry in view of Brexit, and the Falsified Medicines Directive (“FMD”)4. In addition, two interesting keynote speeches on portfolio transformation and the Swiss regulatory system formed part of the program.

II. Summary of Keynote Speeches and Panel Discussions

A. Keynote Speech on Portfolio Transformation in…

[…]
Melden Sie sich für den LSR-Newsletter an und bleiben Sie informiert.